 |
|
COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis
Ka Shing Cheung, Chiu Hang Mok, Xianhua Mao, Ruiqi Zhang, Ivan FN Hung, Wai Kay Seto, Man Fung Yuen
Clin Mol Hepatol. 2022;28(4):890-911. Published online 2022 Jun 3 DOI: https://doi.org/10.3350/cmh.2022.0087
|
|
Citations to this article as recorded by
 High Rate of Antibody Response to Multiple Doses of the COVID-19 Vaccine in Liver Transplant Recipients: Analysis of Predictive Factors
Nunzio Zignani, Andrea Costantino, Michele Sagasta, Clara Dibenedetto, Riccardo Perbellini, Sara Uceda Renteria, Pietro Lampertico, Maria Francesca Donato
Vaccines.2025; 13(4): 352. CrossRef Clinical application of COVID-19 vaccine in liver transplant recipients
Feng-Chao Liu, Man Xie, Wei Rao
Hepatobiliary & Pancreatic Diseases International.2024; 23(4): 339. CrossRef Clinical characteristics and outcomes of liver transplant recipients infected by Omicron during the opening up of the dynamic zero-coronavirus disease policy in China: A prospective, observational study
Wei Zhang, Rongrong Wang, Pingbo Jin, Xinyu Yu, Weili Wang, Yuntao Zhang, Xueli Bai, Tingbo Liang
American Journal of Transplantation.2024; 24(4): 631. CrossRef Ursodeoxycholic acid does not affect the clinical outcome of SARS‐CoV‐2 infection: A retrospective study of propensity score‐matched cohorts
Giuseppe Marrone, Marcello Covino, Giuseppe Merra, Andrea Piccioni, Annamaria Amodeo, Angela Novelli, Rita Murri, Maurizio Pompili, Antonio Gasbarrini, Francesco Franceschi
Liver International.2024; 44(1): 83. CrossRef Effect of ursodeoxycholic acid on preventing SARS-CoV-2 infection in patients with liver transplantation: a multicenter retrospective cohort study
L Hu, H Zhang, C Huang, T Shen, Z Feng, F Mu, L Xu, Y Lin, C Yue, K Guo, M Tian, J Shi, C Zhang, P Wen, S Cao, Y Wang, J Zhang, X Shi, Z Wang, Y He, X Zhang, X Liu, Y Lv, Z Liu, W Guo, B Wang
QJM: An International Journal of Medicine.2024; 117(5): 339. CrossRef Advancements in Vaccine Strategies for Chronic Liver Disease Patients: Navigating Post-COVID Challenges and Opportunities
Samer Al-Dury, Nelly Kanberg
Vaccines.2024; 12(2): 197. CrossRef Third vaccine boosters and anti‐S‐IgG levels: A comparison of homologous and heterologous responses and poor immunogenicity in hepatocellular carcinoma
Chih‐Wen Wang, Chung‐Feng Huang, Tyng‐Yuan Jang, Ming‐Lun Yeh, Po‐Cheng Liang, Yu‐Ju Wei, Po‐Yao Hsu, Ching‐I. Huang, Ming‐Yen Hsieh, Yi‐Hung Lin, Jee‐Fu Huang, Chia‐Yen Dai, Wan‐Long Chuang, Ming‐Lung Yu
The Kaohsiung Journal of Medical Sciences.2024; 40(5): 477. CrossRef Klinische Verläufe und Kosten für Hospitalisierungen von COVID-19-Patienten mit potenziell eingeschränktem Immunsystem in Deutschland
Dennis Häckl, Marc Pignot, Phi Long Dang, Victoria Lauenroth, Fungwe Jah, Clemens-Martin Wendtner
DMW - Deutsche Medizinische Wochenschrift.2024; 149(07): e38. CrossRef Immunogenicity of COVID-19 vaccines in patients with cirrhosis: A meta-analysis
Lichen Ouyang, Gang Lei, Yeli Gong
Human Vaccines & Immunotherapeutics.2024;[Epub] CrossRef Association between Gut Microbiota Composition and Long-Term Vaccine Immunogenicity following Three Doses of CoronaVac
Li-Na Zhang, Jing-Tong Tan, Ho-Yu Ng, Yun-Shi Liao, Rui-Qi Zhang, Kwok-Hung Chan, Ivan Fan-Ngai Hung, Tommy Tsan-Yuk Lam, Ka-Shing Cheung
Vaccines.2024; 12(4): 365. CrossRef Proton pump inhibitors associated with severe COVID‐19 among two‐dose but not three‐dose vaccine recipients
Ka Shing Cheung, Vincent K C Yan, Xuxiao Ye, Ivan F N Hung, Esther W Chan, Wai K Leung
Journal of Gastroenterology and Hepatology.2024; 39(9): 1837. CrossRef Serological responses to COVID-19 vaccination in patients with chronic liver diseases
Yu-Shan Huang, Szu-Min Hsieh, Feng-Chiao Tsai, Chien-Chih Tung, Hung-Chih Yang, Sui-Yuan Chang, Jann-Tay Wang, Chun-Jen Liu, Tung-Hung Su, Jia-Horng Kao
Journal of the Formosan Medical Association.2024; 123(11): 1194. CrossRef Effect of metabolic dysfunction‐associated steatotic liver disease on BNT162b2 immunogenicity against the severe acute respiratory syndrome coronavirus 2 omicron variant
Lok Ka Lam, Jing Tong Tan, Poh Hwa Ooi, Ruiqi Zhang, Kwok Hung Chan, Xianhua Mao, Ivan F N Hung, Wai Kay Seto, Man Fung Yuen, Ka Shing Cheung
Journal of Gastroenterology and Hepatology.2024; 39(11): 2386. CrossRef Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Clinical and Molecular Hepatology.2023; 29(1): 168. CrossRef Correspondence on Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”
Ka Shing Cheung, Chiu Hang Mok, Wai Kay Seto, Man Fung Yuen
Clinical and Molecular Hepatology.2023; 29(1): 176. CrossRef Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination
Riccardo Nevola, Livio Criscuolo, Domenico Beccia, Augusto Delle Femine, Rachele Ruocco, Simona Imbriani, Maria Alfano, Angela Villani, Antonio Russo, Pasquale Perillo, Raffaele Marfella, Luigi Elio Adinolfi, Ferdinando Carlo Sasso, Aldo Marrone, Luca Rin
World Journal of Gastroenterology.2023; 29(5): 800. CrossRef Association between Gut Microbiota and SARS-CoV-2 Infection and Vaccine Immunogenicity
Ho Yu Ng, Wai K. Leung, Ka Shing Cheung
Microorganisms.2023; 11(2): 452. CrossRef Effect of Moderate to Severe Hepatic Steatosis on Vaccine Immunogenicity against Wild-Type and Mutant Virus and COVID-19 Infection among BNT162b2 Recipients
Ka Shing Cheung, Lok Ka Lam, Xianhua Mao, Jing Tong Tan, Poh Hwa Ooi, Ruiqi Zhang, Kwok Hung Chan, Ivan F. N. Hung, Wai Kay Seto, Man Fung Yuen
Vaccines.2023; 11(3): 497. CrossRef Analysis of Antibody Responses After COVID-19 Vaccination in Liver Transplant Recipients: A Single-Center Study
Young Ju Oh, Jongman Kim, Eun-Suk Kang, Jinsoo Rhu, Gyu-Seong Choi, Jae-Won Joh
Journal of Korean Medical Science.2023;[Epub] CrossRef Research Progress of Novel Coronavirus Vac-cine in Patients with Chronic Liver Disease
露 王
Advances in Clinical Medicine.2023; 13(04): 6745. CrossRef Humoral Immune Response after COVID-19 mRNA Vaccination in Patients with Liver Cirrhosis: A Prospective Real-Life Single Center Study
Elisa Biliotti, Alessandro Caioli, Chiara Sorace, Raffaella Lionetti, Eugenia Milozzi, Chiara Taibi, Ubaldo Visco Comandini, Fabrizio Maggi, Vincenzo Puro, Gianpiero D’Offizi
Biomedicines.2023; 11(5): 1320. CrossRef COVID‑19 vaccination in liver transplant recipients (Review)
Aikaterini Gkoufa, Maria Saridaki, Vasiliki Georgakopoulou, Demetrios Spandidos, Evangelos Cholongitas
Experimental and Therapeutic Medicine.2023;[Epub] CrossRef Meta‐analysis of the immunogenicity of standard and booster SARS‐CoV‐2 vaccination in patients with chronic liver disease and post‐liver transplantation
Wen‐Xin Wang, Jitao Wang, Rui Jia, Silvia Martini, Jiaye Liu, Yifei Huang, Fu‐Sheng Wang, Xiaolong Qi, Junliang Fu
Portal Hypertension & Cirrhosis.2023; 2(2): 61. CrossRef Mycophenolate Interruption Restores Anti-SARS-CoV-2 Vaccine Immunogenicity in Unresponsive Liver Transplant Recipients
Pierluigi Toniutto, Annarosa Cussigh, Sara Cmet, Martina Fabris, Francesco Curcio, Davide Bitetto, Ezio Fornasiere, Elisa Fumolo, Edmondo Falleti
Vaccines.2023; 11(7): 1165. CrossRef The vaccine-response in patients with cirrhosis after COVID-19 vaccination: A systematic analysis of 168,245 patients with cirrhosis
Zheng Li, Yue Hu, Bingwen Zou
Journal of Hepatology.2023; 79(4): e157. CrossRef Research landscape on COVID-19 and liver dysfunction: A bibliometric analysis
Sa'ed H Zyoud
World Journal of Gastroenterology.2023; 29(27): 4356. CrossRef Susceptibility to SARS-CoV-2 Infection and Immune Responses to COVID-19 Vaccination Among Recipients of Solid Organ Transplants
Vijay Subramanian
The Journal of Infectious Diseases.2023; 228(Supplement): S34. CrossRef Metabolic Associated Fatty Liver Disease (MAFLD) and COVID-19 Infection: An Independent Predictor of Poor Disease Outcome?
Vladimir Milivojević, Jelena Bogdanović, Ivana Babić, Nevena Todorović, Ivan Ranković
Medicina.2023; 59(8): 1438. CrossRef Antibiotic Use Prior to COVID-19 Vaccine Is Associated with Higher Risk of COVID-19 and Adverse Outcomes: A Propensity-Scored Matched Territory-Wide Cohort
Ka Shing Cheung, Vincent K. C. Yan, Lok Ka Lam, Xuxiao Ye, Ivan F. N. Hung, Esther W. Chan, Wai K. Leung
Vaccines.2023; 11(8): 1341. CrossRef COVID-19 and Liver Disease: An Evolving Landscape
Kai Zhu, Olivia Tsai, Daljeet Chahal, Trana Hussaini, Eric M. Yoshida
Seminars in Liver Disease.2023; 43(03): 351. CrossRef Factors influencing immunogenicity and safety of SARS-CoV-2 vaccine in liver transplantation recipients: a systematic review and meta-analysis
Xinyi Luo, Fabrice Yves Ndjana Lessomo, Zhimin Yu, Yong Xie
Frontiers in Immunology.2023;[Epub] CrossRef Impact of SARS-CoV-2 Infection on Humoral and Cellular Immunity in a Cohort of Vaccinated Solid Organ Transplant Recipients
Bernardo Ayala-Borges, Miguel Escobedo, Natalia Egri, Sabina Herrera, Marta Crespo, Sonia Mirabet, Carlos Arias-Cabrales, Anna Vilella, Eduard Palou, María M. Mosquera, Mariona Pascal, Jordi Colmenero, Marta Farrero, Marta Bodro
Vaccines.2023; 11(12): 1845. CrossRef COVID-19 vaccine and hepatitis: A mini review
Beuy Joob, Viroj Wiwanitkit
Indian Journal of Allergy, Asthma and Immunology.2023; 37(2): 37. CrossRef COVID-19 Vaccination in Patients with Chronic Liver Disease
Georgios Schinas, Eleni Polyzou, Fevronia Mitropetrou, Aristotelis Pazionis, Charalambos Gogos, Christos Triantos, Karolina Akinosoglou
Viruses.2022; 14(12): 2778. CrossRef
|